Interleukin-1 family cytokines and their regulatory proteins in normal pregnancy and pre-eclampsia

Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice

(2014) B. Wu et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The IL-1 Family Member 7b Translocates to the Nucleus and Down-Regulates Proinflammatory Cytokines

(2014) S. Sharma et al.   JOURNAL OF IMMUNOLOGY

Epithelial expression of interleukin-37b in inflammatory bowel disease

(2013) H. Imaeda et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Macrophage-Derived IL-33 Is a Critical Factor for Placental Growth

(2013) V. Fock et al.   JOURNAL OF IMMUNOLOGY

Serum Interleukin-37 Concentrations and HBeAg Seroconversion in Chronic HBV Patients During Telbivudine Treatment

(2013) Cong Li et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Cell-cell communication via extracellular membrane vesicles and its role in the immune response

(2013) Inkyu Hwang   MOLECULES AND CELLS

IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells

(2012) S. Vigne et al.   BLOOD

IL-36 in psoriasis

(2012) JE Towne et al.   CURRENT OPINION IN PHARMACOLOGY

Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells

(2012) Nozomu Sakai et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Placental Secretion of Interleukin-1 and Interleukin-1 Receptor Antagonist in Preeclampsia: Effect of Magnesium Sulfate

(2012) Alaa Amash et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia

(2012) C.W.G. Redman et al.   PLACENTA

IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist

(2012) F. L. van de Veerdonk et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Preeclampsia: A multi-stress disorder

(2012) C.W.G. Redman   REVUE DE MEDECINE INTERNE

Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis

(2011) Alexandros Onoufriadis et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Elevated Serum Levels of Interleukin-6, Interleukin-1β and Human Chorionic Gonadotropin in Pre-eclampsia

(2011) Michail Kalinderis et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

IL-36R ligands are potent regulators of dendritic and T cells

(2011) S. Vigne et al.   BLOOD

Role of IL-33 in inflammation and disease

(2011) Ashley M Miller   Journal of Inflammation-London

Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis

(2011) Slaheddine Marrakchi et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Immunomodulatory Role of Syncytiotrophoblast Microvesicles

(2011) Jennifer Southcombe et al.   PLoS One

ST2 and IL-33 in Pregnancy and Pre-Eclampsia

(2011) Ingrid Granne et al.   PLoS One

In Vivo Expression of Interleukin-37 Reduces Local and Systemic Inflammation in Concanavalin A-Induced Hepatitis

(2011) Ana-Maria Bulau et al.   TheScientificWorldJOURNAL

Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array

(2010) Andras Szarka et al.   BMC IMMUNOLOGY

Local overexpression of interleukin-1 family, member 6 relates to the development of tubulointerstitial lesions

(2010) Osamu Ichii et al.   LABORATORY INVESTIGATION

Pre-eclampsia

(2010) Eric AP Steegers et al.   LANCET

IL-37 is a fundamental inhibitor of innate immunity

(2010) Marcel F Nold et al.   NATURE IMMUNOLOGY

Immunological and Inflammatory Functions of the Interleukin-1 Family

(2009) Charles A. Dinarello   Annual Review of Immunology

Systemic Increase in the Ratio between Foxp3+ and IL-17-Producing CD4+ T Cells in Healthy Pregnancy but Not in Preeclampsia

(2009) B. Santner-Nanan et al.   JOURNAL OF IMMUNOLOGY

Placental Stress and Pre-eclampsia: A Revised View

(2009) C.W.G. Redman et al.   PLACENTA

Inflammation and Pregnancy

(2009) John R. Challis et al.   Reproductive Sciences

Ischemic-reperfusion syndromes: Biochemical and immunologic rationale for IL-1 targeted therapy

(2008) Alan A. Wanderer   CLINICAL IMMUNOLOGY

The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33

(2008) Gaby Palmer et al.   CYTOKINE